It has previously been suggested that, in women with central adiposity, failure of IGFBP-1 to be suppressed by more than 40% after an oral glucose challenge identifies a group at high risk of increasing abdominal adiposity and diabetes [36]. Here, IGFBP1 is linked to diabetes mellitus.